Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutamate receptor ionotropic, kainate 1 (GluK1), encoded by the GRIK1 gene, is a subunit of the ionotropic glutamate receptor family that functions as a ligand-gated ion channel. It mediates fast excitatory neurotransmission in both the central and peripheral nervous systems by allowing the influx of cations (such as sodium and calcium) upon binding to glutamate or kainate. Beyond its canonical ionotropic role, GluK1 is also involved in noncanonical metabotropic signaling through G-protein coupling, which modulates the release of other neurotransmitters like GABA. GluK1 is highly expressed in key brain regions, including the hippocampus, amygdala, and dorsal root ganglia, making it a critical player in synaptic plasticity, sensory processing, and pain transmission. Consequently, GluK1 is a major therapeutic target for neurological and psychiatric disorders, including epilepsy, migraine, chronic pain, and alcohol use disorder. Pharmacological modulation of GluK1, particularly through selective antagonists like tezampanel and LY466195, aims to reduce neuronal hyperexcitability and has shown therapeutic potential in clinical and preclinical models.
Antagonist, Agonist, Allosteric modulator
12 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutamate receptor ionotropic, kainate 1 (GluK1).